Scarica l'app Stockscreener
1.22
3.39%
0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$1.18
Aprire:
$1.17
Volume 24 ore:
271.95K
Relative Volume:
1.93
Capitalizzazione di mercato:
$26.45M
Reddito:
$179.02M
Utile/perdita netta:
$-57.29M
Rapporto P/E:
-0.4438
EPS:
-2.7487
Flusso di cassa netto:
$-33.01M
1 W Prestazione:
+3.39%
1M Prestazione:
-21.29%
6M Prestazione:
-45.29%
1 anno Prestazione:
-55.64%
Intervallo 1D:
$1.1699
$1.2651
Intervallo di 1 settimana:
$1.15
$1.2651
Portata 52W:
$1.15
$4.10
Petmed Express Inc Stock (PETS) Company Profile
Nome
Petmed Express Inc
Settore
Industria
Telefono
(561) 426-4444
Indirizzo
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, SCNX, POM, RDGT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
1.22 | 26.45M | 179.02M | -57.29M | -33.01M | -2.7487 |
HITI
High Tide Inc
|
2.59 | 230.88M | 486.49M | -33.29M | 10.86M | -0.3627 |
SCNX
Scienture Holdings Inc
|
2.88 | 4.73M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
1.17 | 3.25M | 0 | 0 | 0 | 0.00 |
RDGT
Ridgetech Inc
|
0.801 | 2.91M | 111.62M | 762.70K | 16.36M | -85.73 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-05-25 | Iniziato | Lake Street | Buy |
| 2022-01-20 | Aggiornamento | Sidoti | Neutral → Buy |
| 2021-11-18 | Iniziato | Morgan Stanley | Underweight |
| 2021-10-01 | Iniziato | Jefferies | Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-06-03 | Downgrade | Sidoti | Buy → Neutral |
| 2021-03-05 | Aggiornamento | Sidoti | Neutral → Buy |
| 2021-01-27 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-19 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-04-09 | Downgrade | Sidoti | Buy → Neutral |
| 2020-03-12 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-02-24 | Downgrade | Sidoti | Buy → Neutral |
| 2019-08-16 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-06-15 | Iniziato | CL King | Neutral |
| 2017-08-24 | Aggiornamento | Sidoti | Neutral → Buy |
| 2017-07-24 | Aggiornamento | Northcoast | Neutral → Buy |
| 2016-05-09 | Aggiornamento | Craig Hallum | Sell → Hold |
| 2016-02-04 | Iniziato | Credit Suisse | Underperform |
| 2010-07-19 | Downgrade | CL King | Strong Buy → Accumulate |
| 2010-07-19 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-05-25 | Downgrade | Wedbush | Neutral → Underperform |
| 2010-05-06 | Reiterato | Wedbush | Neutral |
| 2010-03-23 | Downgrade | Janney Mntgmy Scott | Buy → Neutral |
| 2010-03-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2010-02-16 | Reiterato | CL King | Strong Buy |
| 2009-07-21 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2009-01-07 | Iniziato | CL King | Strong Buy |
Mostra tutto
Petmed Express Inc Borsa (PETS) Ultime notizie
PetMed Express stock gains 4.35 percent on Nasdaq. Morgan Stanley holds USD 1.40 target - AD HOC NEWS
PetMed Express, Inc. Actuals & Estimates (HAM:PQM) - TradingView
PetMed Express (Nasdaq:PETS)Stock Analysis - Simply Wall Street
PetMed Express appointed Tamar Elkeles and PetMed Express stock stayed unchanged - AD HOC NEWS
Cash flow from operating activities of PetMed Express, Inc. – HAN:PQM - TradingView
PetMed Express CEO Jeffrey Willard Granted 500,000 Shares in Equity Awards - Kalkine Media
Current ratio of PetMed Express, Inc. – HAN:PQM - TradingView
PetMed Express CEO Jeffrey Allen Willard Files Initial SEC Ownership Disclosure - Kalkine Media
A 250,000-share restricted award goes to PetMed Express (PETS) CEO. Another grant hinges on returns. - stocktitan.net
Jeffrey Allen Willard, CEO and president of PetMed Express (PETS), is named in an initial ownership report. - stocktitan.net
PetMed Express Files to Register 1.8 Million Additional Shares Under Updated 2024 Incentive Plan - Kalkine Media
PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan - TradingView
PETS Maintains Rating by Morgan Stanley -- Price Target Lowered to $1.40 - gurufocus.com
PetMed Express Is Maintained at Underweight by Morgan Stanley - Moomoo
Form 8K PetMed Express Inc For: 22 September By Investing.com - Investing.com Canada
PetMed Express appoints Tamar Elkeles to board of directors By Investing.com - Investing.com Nigeria
PetMed Express appoints Tamar Elkeles to board of directors - Investing.com
PetMeds Appoints Tamar Elkeles to Board Amid Leadership Transition - citybiz
Qualcomm’s former talent chief joins PetMeds’ board - Stock Titan
PetMed Express Names Jeff Willard CEO Amid Transformation - The Globe and Mail
PetMeds Names Jeff Willard CEO as Justin Mennen Becomes Board Chair - citybiz
PetMeds will get a new CEO Sept. 28 as its board chair retires - Stock Titan
PetMeds Appoints Andrew Parry as Chief Technology Officer - Yahoo Finance
PetMed Express Names Andrew Parry Chief Technology Officer - Yahoo Finance
PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeVolume Dry Up - vinanet.vn
PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeEntry Point Alerts - dars.gov.et
PetMed Express Inc. (PETS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PetMeds (PETS) Q1 FY2027 Results Show Stabilizing Revenue but No Margin Relief Yet - AlphaStreet
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - AOL.com
PetMed Express (PETS) Q1 2027 Earnings Call Transcript - The Globe and Mail
Petwealth and Kennel Connection Accelerate Partnership Following Strong Industry Response at SuperZoo 2026 - AOL.com
PetMed (PETS) Financial Update: EPS Falls Short of Its Estimate at the Close; After Earnings: The Stock Loses 1.67% in Latest TradingShare Repurchase Impact - vinanet.vn
150-year-old Cheltenham pharmacy rescued from administration - AOL.co.uk
Petmed Express Inc (PETS) Stock News Today - TradingKey
Full Transcript: PetMed Express Q1 2027 Earnings Call - Sahm
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y - Yahoo Finance
PetMed Express Q1 2027 Earnings Call Transcript - MarketBeat
PetMed Express (PETS) Fiscal Q1 2027 Earnings Call: Sales Stabilize Above $40 Million - TradingKey
PetMeds® Announces First Quarter Financial Results - The Manila Times
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express Inc (PETS) (Q1 2027) Earnings Call Highlights: Na - GuruFocus
PetMed Express earnings missed by $0.40, revenue fell short of estimates - Investing.com Canada
PetMed Express, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Is PetMed Express Inc (PETS) a Value Opportunity After Q1 Earnin - GuruFocus
PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com Nigeria
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com South Africa
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com
Earnings call transcript: PetMed Express misses Q1 2027 estimates as shares fall - Investing.com
PetMed Express (PETS) grants 60,000 restricted shares to interim CEO Campbell - Stock Titan
Petmed Express Inc Azioni (PETS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.97%
42.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):